Penetration and antiviral efficacy of total and unbound maraviroc, raltegravir and rilpivirine in both female and male genital fluids from HIV-positive patients receiving regimens containing these antiretrovirals
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.